Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A molecular microbiologist, Dr Janjira’s research focusses on using bacterial typing based on genome to confirm which disease is present in a patient. She aims to develop a single whole genome sequence type test using mutliple-PCR assays that can determine from a single sample of blood what bacteria or viruses are present in a patient’s blood - thereby speeding up diagnosis and potentially saving lives in resource-limited settings.

My name is Janjira Thaipadungpanit, I am the Head of Molecular Microbiology at MORU; I do bacterial typing based on genome. We do molecular diagnosis based on real time PCR. Molecular diagnosis is an important laboratory tool: we can confirm which disease people have – something that a microbiology lab or blood culture cannot tell you.

For example, rodents carry leptospira with no symptoms, but leptospira from rat urine contaminates the environment. People acquire the leptospirosis infection by contact with the contaminated environment or by direct contact with infected animals. People at risk of leptospirosis – or melioidosis – are farmers who work daily in rice paddy fields, or fish in a pond. Leptospirosis can lead to multiple organ failure, and in a quarter of cases leads to death.

We have many infections or diseases in this region, and normally we have to do nine PCR assays per patient sample. We don't get enough blood to get all the DNA to cover all the tests that we need to do. We need to develop a test that can do mutliple-PCR that can diagnose more than one test at the same time to save time and to save the DNA or blood from patients. If we could develop a single diagnostic test based on whole genome sequence, a test that uses one sample of blood to diagnose for every virus or bacteria, that would be better. This is the challenge, and we would like to develop that.

Q: What is it like working with international scientists, people from other cultures?

Janjira Thaipadungpanit: I am really happy that I have the opportunity to work here at MORU. Scientists here have time to sit and talk to juniors. When we have questions – what do you think? – then they explain, they listen to you. I think it's a very beautiful, good environment. They don't block your brain, or say you don't think. That is what I love about MORU and all the people here.

Q: How do you feel when your research has an impact on patients?

JT: I feel that what I did is very useful. My research is useful right now for the Thai people. But when it is cited in another country, then it means that it is useful to another country's people as well. Then, for me, I think, I will be a super girl, and that I helped humanity.

Janjira Thaipadungpanit

Microbiology

Head of Molecular Microbiology at MORU, Dr Janjira Thaipadungpanit's research interests include the molecular epidemiology of leptospirosis and melioidosis using multilocus sequence typing or genome data and molecular diagnosis to identify the causes of acute febrile illness and sepsis in patients.

More podcasts related to Global Health

Mike English: Health services that deliver for newborns

Global Health

Basic hospital care may be key to saving newborn lives. Professor Mike English outlines a multidisciplinary project engaging policy-makers and practitioners in Kenya. This project demonstrated poor coverage of Nairobi’s 4.25 million population if a sick newborn baby needs quality hospital care. Using novel research approaches the team also identified how severe shortages of nurses contribute to poor quality of care for patients and negatively affect nurses themselves.

Tran Hien: Infectious diseases in the tropics

Global Health

Although incidence of malaria has decreased in Vietnam, the burden of infectious diseases remains high and weighs heavily on the health care system. Clinical research aims to allow investments to go further: findings in the laboratory, tested in clinical trials and then applied to the community, help improve diagnosis and management.

Ronald Geskus: Sophisticated biostatistics for complex clinical research

Global Health

The role of biostatisticians in clinical research is to contribute to trial design, by calculating sample size for example, and to help draw correct conclusions from the data, discriminating important information from noise. They are instrumental in the translation of a practical problem into a statistical model, and the translation of the result into practice.

Rogier Van Doorn: Research at OUCRU Hanoi

Global Health

Antibiotics are widely used in Vietnam, leading to widespread antimicrobial resistance. Monitoring antibiotic use helps inform the government to change treatment guidelines and implement antibiotic stewardship programmes. This may also prevent the transmission of resistant bacteria outside the country.

Heiman Wertheim: Clinical research in low and middle-income countries

Global Health

Drug resistant infections are a global crisis and we cannot focus on our own country only. Clinical trials in low and middle income countries where the burden is highest, as well as work with local communities and engagement with policy makers help influence public health policies.

Guy Thwaites: Tuberculosis meningitis

Global Health

Tuberculosis meningitis affects a fractions of TB patients but causes high levels of mortality and morbidity. A recent trial at OUCRU showed that aspirin can greatly improve outcomes. Such trial is typical of the work done in our Vietnam units, where all the research is focussed on improving the outcome for patients directly.

Motiur Rahman: OUCRU laboratory management

Global Health

OUCRU laboratories provide support to the unit’s extensive clinical research programme, from level 2 laboratory to SAPO 4 laboratory for high-risk pathogens responsible for zoonotic infections. Early diagnosis and detection of antimicrobial resistance helps prescribe the right medicine in time, contributing to better patient management.

Raph Hamers: Developing collaborative clinical trials in Indonesia

Global Health

Indonesia is a very populous country with a huge burden of infectious diseases such as TB, malaria, HIV and CNS infections. Running clinical trials requires high levels of expertise, currently developed and strengthened by institutions such as IOCRL (Universities of Indonesia and Oxford Clinical Research laboratory). Better collaborations will also help great ideas make a bigger impact.

Jeremy Day: Central nervous system and HIV infections in Vietnam

Global Health

Brain infections such as meningitis and encephalitis are highly debilitating diseases, and an accurate diagnostic is essential to give patients the best treatment available. For cryptococcal meningitis, clinical trials focus on prevention, for an early diagnosis, and novel ways to use existing treatments or repurpose old drugs.

Abhilasha Karkey: Connecting research with communities in Nepal

Global Health

Antimicrobial resistance is a huge burden in Nepal, particularly in hospitals where many nosocomial infections are caused by resistant pathogens. With limited resources, little infection controls and proper guidelines in place, finding out the main risk factors helps reduce infection rates within a hospital and better target vaccination campaigns.

Translational Medicine

From Bench to Bedside

Ultimately, medical research must translate into improved treatments for patients. At the Nuffield Department of Medicine, our researchers collaborate to develop better health care, improved quality of life, and enhanced preventative measures for all patients. Our findings in the laboratory are translated into changes in clinical practice, from bench to bedside.